CATB

Catabasis Pharmaceuticals, Inc. [CATB] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CATB Stock Summary

In the News

02:37 10 Dec 2023 CATB

Catabasis Renames As Astria Therapeutics With New Disease Focus

Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several years, weighed down mainly by the failure of the edasalonexent program in Duchenne muscular dystrophy.

02:07 10 Dec 2023 CATB

Catabasis Pharmaceuticals Shares: 1-For-6 Split Goes Into Effect

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) deployed a reverse stock split of its shares of common stock at a ratio of 1-for-6. These are the details.

02:24 10 Dec 2023 CATB

Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition

Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition

04:42 10 Dec 2023 CATB

CATB Stock Price Increases Over 40% Pre-Market: Why It Happened

The stock price of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) increased by over 40% pre-market. This is why it happened.

08:00 10 Dec 2023 CATB

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

04:10 10 Dec 2023 CATB

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

12:14 10 Dec 2023 CATB

AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls

With the trading day halfway over, the broad markets were making yet another strong push.

08:00 10 Dec 2023 CATB

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences.

10:46 10 Dec 2023 CATB

CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today

Catabasis Pharma (CATB) stock is soaring higher on Friday after announcing its acquisition of Quellis Biosciences and a PIPE. The post CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today appeared first on InvestorPlace.

12:12 10 Dec 2023 CATB

Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know

Catabasis Pharmaceuticals (CATB) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company. The post Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know appeared first on InvestorPlace.

CATB Financial details

Company Rating
Neutral
Market Cap
234.86M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
13 May 2021
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.01%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
27.5M
Shs Float
11.01M
-
-
-
-
Target Price
-
52W Range
8.48-9.21
52W High
-5.11%
52W Low
+6.75%
RSI
-
Rel Volume
0.19
Avg Volume
528.92K
Volume
98.87K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.66321
-
-
Volatility
0%, 0%
Prev Close
0%
Price
8.54
Change
-

Something similar

Top by Market Cap
Same Sector
Similar Market Cap